About SpaceOAR™ Hydrogel
A little space before prostate radiation can make a BIG difference after.
In a clinical study, SpaceOAR Hydrogel was shown to help minimise the impact on urinary, sexual and bowel quality of life for prostate cancer patients undergoing radiation therapy. 1,2,3
Which leads to a BETTER QUALITY OF LIFE*
*After radiotherapy was complete, control patients experienced a clinically significant (1xMID) decline in bowel, urinary and sexual quality of life 8 times more often than SpaceOAR Hydrogel patients.3,4
The content of this website is for information purposes only and not meant for product promotion or medical diagnostic. This information does not constitute medical or legal advice, and Boston Scientific makes no representation or warranty regarding this information or its completeness, accuracy or timeliness. Accordingly, Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary. As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with SpaceOAR Hydrogel injection; pain or discomfort associated with SpaceOAR Hydrogel; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR Hydrogel into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR Hydrogel intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.
- Data on file with Boston Scientific.
- Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.
- Hamstra DA, Mariados N, Sylvester J, et al. Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):976-85.
- Hamstra D, Shah D, Kurtzman S, et al. Evaluation of sexual function on a randomized trial of a prostate rectal spacer. J Clin Oncol. 2017 February 20;35(Suppl 6):69.
- Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer (IPG590)
Evidence-based recommendations on biodegradable spacer insertion (gel or balloon) to reduce rectal toxicity during radiotherapy for prostate cancer in adults.
Published 23 August 2017